Tirzepatide in Obesity-Driven Endometrial Cancer
Tirzepatide in Obesity-Driven Endometrial Cancer
Recruiting · NCT07065552 · Registry updated 2026-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tirzepatide in Obesity-Driven Endometrial Cancer | Body Weight, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Insulin Resistance, Neoplasms by Site, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, glucose metabolism disease, hyperinsulinism, metabolic disease, neoplasm, nutritional disorder, obesity disorder, overnutrition, uterine disorder | Recruiting | Early phase 1 | 2026-10-02 | NCT07065552 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| UNC Lineberger Comprehensive Cancer Center | 125 |
| United States Department of Defense | 319 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Lineberger Comprehensive Cancer Center | Chapel Hill | United States | 15 |